Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NuviaRx vs TelePeptide

NuviaRx
Graded #72

Higher grade

vs+11.200000000000003
TelePeptide
Graded #276

Lower grade

The verdict

NuviaRx takes it — 73.5/100 to 62.3/100.

NuviaRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuviaRx is a GLP-1 weight-loss telehealth service offering compounded semaglutide (from $140/mo) and tirzepatide (from $170/mo) with transparent pricing and free delivery.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNuviaRx +43
87
44
Dose & formulationTelePeptide +3
72
75
Clinical oversightTelePeptide +5
82
87
Labs & monitoringTelePeptide +1
53
54
FulfillmentTelePeptide +5
72
77
Contract termsNuviaRx +35
55
20
NuviaRx · left barTelePeptide · right bar

The numbers

MetricNuviaRxTelePeptide
WeighScore73.5/10062.3/100
GradeCC
Scorecard rank#72#276
Semaglutide$140/mo (all doses, compounded)$199/mo (starting dose, annual plan, compounded oral)
Tirzepatide$170/mo (all doses, compounded)$219/mo (starting dose, annual plan, compounded oral)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
NuviaRx

Graded #72 · C

Strengths

  • Transparent, affordable pricing — compounded semaglutide from $140/mo, tirzepatide from $170/mo
  • Free delivery included; clinical evaluation and prescription bundled (if eligible)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Informed Consent, Medical Disclaimer)
  • Named operating entity (NuviaRx Health Inc.) with a US address and phone support

Where it loses points

  • Compounding pharmacy partner not named ('partner pharmacy')
  • Not LegitScript-certified (no certification displayed)
  • Lowest pricing is 'as low as' — likely requires a longer prepaid plan
  • State availability not published
TelePeptide

Graded #276 · C

Strengths

  • LegitScript-certified (seal ID 49966407); 503A-licensed compounding pharmacies
  • All-inclusive from $169/mo annual — physician eval + Rx + medication + shipping, no hidden fees
  • Broadest formulation menu: injectable sema/tirz, oral dissolvable tablets, sema+naltrexone, microdose combos
  • 24/7 care team messaging + regular check-ins + dosage adjustments included at every tier
  • 48 states + DC coverage (excludes only AK + MS); no insurance required; cancel anytime

Where it loses points

  • Compounded medications are not FDA-approved; no pharmacy partner named publicly
  • Monthly billing costs more — $199/mo (monthly) vs $169/mo (annual) for semaglutide injectable; best rate requires annual prepay
  • Labs not included in any plan
  • Founder disclosed by first name only (Ahmed); no physician names or clinical leadership disclosed publicly
  • Tirzepatide injectable at $249/mo (monthly billing) is above the compounded market average

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard